Workflow
Plant-based therapeutics
icon
Search documents
Protext Mobility, Inc. (OTC: TXTM) Announces CEO Statement Following Removal of Caveat Emptor Designation
Globenewswire· 2025-10-31 16:19
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Protext Mobility, Inc. (OTC: TXTM) (“TXTM”), an emerging biotechnology company pioneering advancements in plant-based therapeutics, today released an official statement from Chief Executive Officer Mr. Dylon Du Plooy, addressing shareholders in light of the company’s continued operational and strategic progress following the removal of the Caveat Emptor designation. Message to Shareholders: Following the removal of the Caveat Emptor designation, Protext Mobility I ...